The cell culture market size has grown rapidly in recent years. It will grow from $25.14 billion in 2023 to $28.16 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%. The growth observed in the past is primarily due to heightened demand for biopharmaceutical research, expansion in regenerative medicine, vaccine development, increased market demand for vaccines, a surge in chronic diseases, and amplified government funding allocated to research and development initiatives.
The cell culture market size is expected to see strong growth in the next few years. It will grow to $40.3 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the upcoming period can be linked to infectious disease research, increasing demand for biologics, research focused on rare diseases, the upsurge in personalized medicine, advancements in advanced therapies, cell-based assays, and the demand for stem cell therapies. Key trends expected in this period include advancements in cell culture technology, 3D cell culture, organoid culture, bioprocess automation, single-use bioreactors, cultured meat, drug screening and toxicity testing, artificial intelligence and machine learning, cell culture in space, and bioprinting.
The growing prevalence of chronic diseases is fueling the expansion of the cell culture consumables and equipment market. Chronic conditions like cancer, diabetes, heart diseases, obesity, and hypertension are on the rise, with some being linked to cell loss or damage. These diseases can potentially be treated by replacing damaged cells with new ones generated using cell culture consumables and equipment. Hence, the increasing occurrence of chronic diseases has created a heightened demand for such equipment that can facilitate the production of new cells outside the body's natural environment, thereby boosting market growth. For instance, as of September 2023, the World Health Organization reported that chronic diseases account for 74% of all global deaths, claiming the lives of 41 million people annually.
The primary categories within the cell culture consumables and equipment market encompass consumables and instruments. Cell culture instruments consist of various equipment used in cell culture laboratories, including cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, and centrifuges. Consumables comprise essential supplies like media, sera, and reagents. These products find applications in a wide range of fields, including vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, among others. These tools cater to a diverse set of end-users, spanning industrial, biotechnology, agriculture, and more.
The cell culture consumables and equipment market research report is one of a series of new reports that provides cell culture consumables and equipment market statistics, including cell culture consumables and equipment industry global market size, regional shares, competitors with a cell culture consumables and equipment market share, detailed cell culture consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture consumables and equipment industry. This cell culture consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Augmented financial support for cancer research is anticipated to drive the growth of the cell culture consumables and equipment market in the upcoming period. Financial backing, particularly from government bodies like the National Cancer Institute, greatly influences the progress, evolution, and accessibility of cell culture consumables and equipment. For instance, in fiscal year 2023, the United States Congress allotted $7.3 billion to the National Cancer Institute, signifying an upsurge of $408 million from the previous year. As a result, the increased funding for cancer research is a significant driver for the growth of the cell culture consumables and equipment market.
The leading hindrance to the growth of the cell culture consumables and equipment market is the prevalence of contamination within cell cultures. This contamination involves the presence of detrimental foreign microorganisms or non-living elements that negatively affect the cell culture. The usage of contaminated cultures brings adverse effects, thereby limiting the expansion of this market. For example, as per an article published on MedCrave, Mycoplasma, one of the toughest contaminants to detect, showed a significant presence in a study conducted on fibroblast and keratinocyte cell lines. Out of the contaminated cultures, 32.35% had various types of contamination, with mycoplasma contamination accounting for 17.65%, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Consequently, the substantial risk involved in cell culture practices poses a challenge to the growth of the cell culture consumables and equipment market.
Investments in 3D cell culture consumables and equipment are on the rise due to the introduction of novel and advantageous features. 3D cell culture involves the cultivation of live cells using micro-assembled devices and supportive structures, enabling the creation of a three-dimensional framework that emulates artificial environments of tissues or organs. This technique facilitates interactions of cells in all three dimensions, resulting in a higher degree of structural complexity compared to traditional 2D cell cultures. In August 2021, Amerigo Scientific, a US-based manufacturer of biomedical and life sciences products, unveiled specialized 3D cell culture solutions tailored for research purposes.
Key companies within the cell culture consumables and equipment sector are intensifying their focus on the introduction of coated microplates to gain a competitive advantage in the market. Coated microplates constitute a category of laboratory equipment utilized across various biological and chemical assays. These plates are commonly composed of plastic or glass and are coated with a range of materials, including proteins, antibodies, antigens, enzymes, or chemical compounds. For instance, in April 2022, Porvair Sciences Limited, a UK-based producer of analytical laboratory instruments, launched a new line of microplates named Sero Krystal PDL. These microplates are uniquely designed to support cell growth, attachment, and viability in serum-free media. Utilizing Poly-D-Lysine (PDL), a synthetic peptide that enhances cell attachment and growth, and constructed from ultra-pure polystyrene in a controlled environment, the Sero Krystal PDL microplates facilitate consistent cell culture, particularly with challenging cell types. Their applications span various uses, including cell-based assays, high-throughput screening, and drug discovery.
In July 2021, Sartorius, a laboratory instrument manufacturer headquartered in Germany, completed the acquisition of Xell AG for an undisclosed sum. This acquisition was aimed at broadening Sartorius' existing range of media products and expanding their cell culture product line. Xell AG, based in Germany, specializes in cell culture.
Major companies operating in the cell culture market include Becton Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories Private Limited, Lonza Group AG, Merck KGAA, Promocell GmbH, Sartorius AG, Thermo Fisher Scientific Inc., Irvine Scientific Sales Company Inc., CellGenix GmbH, InVitria Inc., Cytiva, Bio-Techne Corporation, GenScript Biotech Corporation, Gedeon Richter Plc., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Bio-Rad Laboratories Inc., Illumina Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Norgen Biotek Corporation, Tecan Group Ltd.
North America was the largest region in the cell culture consumables and equipment market in 2023. Western Europe was the second-largest region in the global cell culture consumables and equipment market share. The regions covered in the cell culture consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the cell culture consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cell culture consumables and equipment market consist of sales of flasks, tubes, dishes or cryovials, serological pipettes or centrifugation tubes, bottles, cell scrapers, strainers, coverslips, and inserts. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The cell culture market size is expected to see strong growth in the next few years. It will grow to $40.3 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the upcoming period can be linked to infectious disease research, increasing demand for biologics, research focused on rare diseases, the upsurge in personalized medicine, advancements in advanced therapies, cell-based assays, and the demand for stem cell therapies. Key trends expected in this period include advancements in cell culture technology, 3D cell culture, organoid culture, bioprocess automation, single-use bioreactors, cultured meat, drug screening and toxicity testing, artificial intelligence and machine learning, cell culture in space, and bioprinting.
The growing prevalence of chronic diseases is fueling the expansion of the cell culture consumables and equipment market. Chronic conditions like cancer, diabetes, heart diseases, obesity, and hypertension are on the rise, with some being linked to cell loss or damage. These diseases can potentially be treated by replacing damaged cells with new ones generated using cell culture consumables and equipment. Hence, the increasing occurrence of chronic diseases has created a heightened demand for such equipment that can facilitate the production of new cells outside the body's natural environment, thereby boosting market growth. For instance, as of September 2023, the World Health Organization reported that chronic diseases account for 74% of all global deaths, claiming the lives of 41 million people annually.
The primary categories within the cell culture consumables and equipment market encompass consumables and instruments. Cell culture instruments consist of various equipment used in cell culture laboratories, including cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, and centrifuges. Consumables comprise essential supplies like media, sera, and reagents. These products find applications in a wide range of fields, including vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, among others. These tools cater to a diverse set of end-users, spanning industrial, biotechnology, agriculture, and more.
The cell culture consumables and equipment market research report is one of a series of new reports that provides cell culture consumables and equipment market statistics, including cell culture consumables and equipment industry global market size, regional shares, competitors with a cell culture consumables and equipment market share, detailed cell culture consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture consumables and equipment industry. This cell culture consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Augmented financial support for cancer research is anticipated to drive the growth of the cell culture consumables and equipment market in the upcoming period. Financial backing, particularly from government bodies like the National Cancer Institute, greatly influences the progress, evolution, and accessibility of cell culture consumables and equipment. For instance, in fiscal year 2023, the United States Congress allotted $7.3 billion to the National Cancer Institute, signifying an upsurge of $408 million from the previous year. As a result, the increased funding for cancer research is a significant driver for the growth of the cell culture consumables and equipment market.
The leading hindrance to the growth of the cell culture consumables and equipment market is the prevalence of contamination within cell cultures. This contamination involves the presence of detrimental foreign microorganisms or non-living elements that negatively affect the cell culture. The usage of contaminated cultures brings adverse effects, thereby limiting the expansion of this market. For example, as per an article published on MedCrave, Mycoplasma, one of the toughest contaminants to detect, showed a significant presence in a study conducted on fibroblast and keratinocyte cell lines. Out of the contaminated cultures, 32.35% had various types of contamination, with mycoplasma contamination accounting for 17.65%, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Consequently, the substantial risk involved in cell culture practices poses a challenge to the growth of the cell culture consumables and equipment market.
Investments in 3D cell culture consumables and equipment are on the rise due to the introduction of novel and advantageous features. 3D cell culture involves the cultivation of live cells using micro-assembled devices and supportive structures, enabling the creation of a three-dimensional framework that emulates artificial environments of tissues or organs. This technique facilitates interactions of cells in all three dimensions, resulting in a higher degree of structural complexity compared to traditional 2D cell cultures. In August 2021, Amerigo Scientific, a US-based manufacturer of biomedical and life sciences products, unveiled specialized 3D cell culture solutions tailored for research purposes.
Key companies within the cell culture consumables and equipment sector are intensifying their focus on the introduction of coated microplates to gain a competitive advantage in the market. Coated microplates constitute a category of laboratory equipment utilized across various biological and chemical assays. These plates are commonly composed of plastic or glass and are coated with a range of materials, including proteins, antibodies, antigens, enzymes, or chemical compounds. For instance, in April 2022, Porvair Sciences Limited, a UK-based producer of analytical laboratory instruments, launched a new line of microplates named Sero Krystal PDL. These microplates are uniquely designed to support cell growth, attachment, and viability in serum-free media. Utilizing Poly-D-Lysine (PDL), a synthetic peptide that enhances cell attachment and growth, and constructed from ultra-pure polystyrene in a controlled environment, the Sero Krystal PDL microplates facilitate consistent cell culture, particularly with challenging cell types. Their applications span various uses, including cell-based assays, high-throughput screening, and drug discovery.
In July 2021, Sartorius, a laboratory instrument manufacturer headquartered in Germany, completed the acquisition of Xell AG for an undisclosed sum. This acquisition was aimed at broadening Sartorius' existing range of media products and expanding their cell culture product line. Xell AG, based in Germany, specializes in cell culture.
Major companies operating in the cell culture market include Becton Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories Private Limited, Lonza Group AG, Merck KGAA, Promocell GmbH, Sartorius AG, Thermo Fisher Scientific Inc., Irvine Scientific Sales Company Inc., CellGenix GmbH, InVitria Inc., Cytiva, Bio-Techne Corporation, GenScript Biotech Corporation, Gedeon Richter Plc., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Bio-Rad Laboratories Inc., Illumina Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Norgen Biotek Corporation, Tecan Group Ltd.
North America was the largest region in the cell culture consumables and equipment market in 2023. Western Europe was the second-largest region in the global cell culture consumables and equipment market share. The regions covered in the cell culture consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the cell culture consumables and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The cell culture consumables and equipment market consist of sales of flasks, tubes, dishes or cryovials, serological pipettes or centrifugation tubes, bottles, cell scrapers, strainers, coverslips, and inserts. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Cell Culture Market Characteristics3. Cell Culture Market Trends And Strategies31. Global Cell Culture Market Competitive Benchmarking32. Global Cell Culture Market Competitive Dashboard33. Key Mergers And Acquisitions In The Cell Culture Market
4. Cell Culture Market - Macro Economic Scenario
5. Global Cell Culture Market Size and Growth
6. Cell Culture Market Segmentation
7. Cell Culture Market Regional And Country Analysis
8. Asia-Pacific Cell Culture Market
9. China Cell Culture Market
10. India Cell Culture Market
11. Japan Cell Culture Market
12. Australia Cell Culture Market
13. Indonesia Cell Culture Market
14. South Korea Cell Culture Market
15. Western Europe Cell Culture Market
16. UK Cell Culture Market
17. Germany Cell Culture Market
18. France Cell Culture Market
19. Italy Cell Culture Market
20. Spain Cell Culture Market
21. Eastern Europe Cell Culture Market
22. Russia Cell Culture Market
23. North America Cell Culture Market
24. USA Cell Culture Market
25. Canada Cell Culture Market
26. South America Cell Culture Market
27. Brazil Cell Culture Market
28. Middle East Cell Culture Market
29. Africa Cell Culture Market
30. Cell Culture Market Competitive Landscape And Company Profiles
34. Cell Culture Market Future Outlook and Potential Analysis
35. Appendix
Executive Summary
Cell Culture Consumables And Equipment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on cell culture consumables and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for cell culture consumables and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered: 1) By Product: Consumables; Instruments; 3) By Application: Vaccination; Toxicity testing; Cancer Research; Drug Screening and Development; Recombinant Products; Stem cell technology; Regenerative Medicine; Other End Users; 2) By End User: Industrial; Biotechnology; Agriculture; Other End Users
- Subsegment: Media; Sera; Reagents; Cell Culture Vessels; Bioreactors; Biosafety Cabinets; Carbon Dioxide Incubators; Centrifuges
- Companies Mentioned: Becton Dickinson and Company; Corning Inc.; Danaher Corporation; Eppendorf AG; HiMedia Laboratories Private Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Becton Dickinson and Company
- Corning Inc.
- Danaher Corporation
- Eppendorf AG
- HiMedia Laboratories Private Limited
- Lonza Group AG
- Merck KGAA
- Promocell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Irvine Scientific Sales Company Inc.
- CellGenix GmbH
- InVitria Inc.
- Cytiva
- Bio-Techne Corporation
- GenScript Biotech Corporation
- Gedeon Richter Plc.
- Hetero Drugs Limited
- Intas Pharmaceuticals Ltd.
- LG Chem Ltd.
- Lupin Limited
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Qiagen NV
- F. Hoffmann-La Roche Ltd
- Norgen Biotek Corporation
- Tecan Group Ltd.